Systemic lupus erythematosus (SLE) is a severe chronic inflammatory autoimmune connective tissue disease. Despite major efforts, SLE remains a poorly understood disease with unpredictable course, unknown etiology and complex pathogenesis. Apoptosis combined with deficiency in clearing apoptotic cells is an important etiopathogenic event in SLE, which could contribute to the increased load of potential autoantigen(s); however, the lack of disease-specific protein signatures deciphering SLE and the underlying biological processes is striking and represents a key limitation. In this retrospective pilot study, we explored the immune system as a specific sensor for disease, in order to advance our understanding of SLE. To this end, we determined multiplexed serum protein expression profiles of crude SLE serum samples, using antibody microarrays. The aim was to identify differential immunoprofiles, or snapshots of the immune response modulated by the disease, reflecting apoptosis, a key process in the etiology of SLE and disease activity. The results showed that multiplexed panels of SLE-associated serum biomarkers could be decoded, in particular reflecting disease activity, but potentially the apoptosis process as well. While the former biomarkers could display a potential future use for prognosis, the latter biomarkers might help shed further light on the apoptosis process taking place in SLE.
PodolskaMJBiermannMHMaueroderCHahnJHerrmannM. Inflammatory etiopathogenesis of systemic lupus erythematosus: An update. J Inflamm Res2015; 8: 161–171.
6.
WangLWangFSGershwinME. Human autoimmune diseases: A comprehensive update. J Intern Med2015; 278: 369–395.
7.
BiermannMHVeissiSMaueroderC, et al.The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: Dendritic cells as potential targets. Expert Rev Clin Immunol2014; 10: 1151–1164.
8.
MunozLEVan BavelCFranzSBerdenJHerrmannMVan der VlagJ. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus2008; 17: 371–375.
9.
BengtssonAAGullstrandBTruedssonLSturfeltG. SLE serum induces classical caspase-dependent apoptosis independent of death receptors. Clin Immunol2008; 126: 57–66.
10.
BengtssonAASturfeltGGullstrandBTruedssonL. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus: An additional mechanism to increase autoantigen load?Clin Exp Immunol2004; 135: 535–543.
11.
RahmanAIsenbergDA. Systemic lupus erythematosus. N Engl J Med2008; 358: 929–939.
12.
LorberMGershwinMEShoenfeldY. The coexistence of systemic lupus erythematosus with other autoimmune diseases: The kaleidoscope of autoimmunity. Semin Arthritis Rheum1994; 24: 105–113.
MerrillJTBuyonJP. The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol2005; 19: 709–726.
15.
RovinBHBirminghamDJNagarajaHNYuCYHebertLA. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Joint Dis2007; 65: 187–193.
16.
MokCC. Biomarkers for lupus nephritis: A critical appraisal. J Biomed Biotechnol2010. 2010: 638413.
17.
LiuCCKaoAHManziSAhearnJM. Biomarkers in systemic lupus erythematosus: Challenges and prospects for the future. Ther Adv Musculoskelet Dis2013; 5: 210–233.
18.
SuiWHouXCheWYangMDaiY. The applied basic research of systemic lupus erythematosus based on the biological omics. Genes Immun2013; 14: 133–146.
19.
IngvarssonJLarssonASjoholmAG, et al.Design of recombinant antibody microarrays for serum protein profiling: Targeting of complement proteins. J Proteome Res2007; 6: 3527–3536.
20.
WingrenCIngvarssonJDexlinLSzulDBorrebaeckCAK. Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling-tag and solid support. Proteomics2007; 7: 3055–3065.
21.
CarlssonAWuttgeDMIngvarssonJ, et al.Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol Cell Proteomics2011; 10.
22.
PeterssonLDexlin-MellbyLBengtssonAASturfeltGBorrebaeckCAKWingrenC. Multiplexing of miniaturized planar antibody arrays for serum protein profiling: A biomarker discovery in SLE nephritis. Lab Chip2014; 14: 1931–1942.
23.
Delfani P, Dexlin ML, Nordström M, et al. Technical advances of the recombinant antibody microarray technology platform for clinical immunoproteomics. PLoS One 2016; 11: e0159138.
24.
FultonKMTwineSM. Immunoproteomics: Current technology and applications. Methods Mol Biol2013; 1061: 21–57.
TanEMCohenASFriesJF, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
27.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
OlssonNWallinSJamesPBorrebaeckCAWingrenC. Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties. Protein Sci2012; 21: 1897–1910.
30.
SoderlindEStrandbergLJirholtP, et al.Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol2000; 18: 852–856.
31.
Säll A, Walle M, Wingren C, et al. Generation and analyses of human synthetic antibody libraries and their application for protein microarrays. Protein Eng Des Sel 2016 In press. http://www.ncbi.nlm.nih.gov/pubmed/27590051.
32.
BorrebaeckCAKWingrenC. Recombinant antibodies for the generation of antibody arrays. Methods Mol Biol2011; 785: 247–262.
33.
IngvarssonJWingrenCCarlssonA, et al.Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics2008; 8: 2211–2219.
34.
PerssonJBackstromMJohanssonHJirstromKHanssonGCOhlinM. Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells. Tumour Biol2009; 30: 221–231.
35.
Dexlin-MellbyLSandstromACentlowM, et al.Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays. Proteom Clin Appl2010; 4: 794–807.
36.
GustavssonEEkSSteenJ, et al.Surrogate antigens as targets for proteome-wide binder selection. N Biotechnol2011; 28: 302–311.
37.
KristenssonMOlssonKCarlsonJ, et al.Design of recombinant antibody microarrays for urinary proteomics. Proteomics Clin Appl2012; 6: 291–296.
38.
PaulyFDexlin-MellbyLEkS, et al.Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays. J Proteome Res2013; 12: 5943–5953.
39.
CarlssonAWingrenCIngvarssonJ, et al.Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Europ J Cancer2008; 44: 472–480.
40.
IhakaRGentlemanRR. A language for data analysis and graphics. J Comput Graph Stat1996; 5: 299–314.
41.
CristianiniNShawe-TaylorJ. An introduction to support vector machines and other kernel-based learning methods, New York: Cambridge University Press, 2000. p. 189.
42.
ChangC-CLinC-J. LIBSVM: A library for support vector machines. ACM Trans Intell Syst Technol2011; 2: 1–27.
43.
GardnerIAGreinerM. Receiver-operating characteristic curves and likelihood ratios: Improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests. Vet Clin Pathol2006; 35: 8–17.
44.
BenjaminiYHochbergY. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc B Met1995; 57: 289–300.
45.
CarlssonAWingrenCKristenssonM, et al.Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc Natl Acad Sci USA2011; 108: 14252–14257.
46.
NorrisPSWareCF. The LT beta R signaling pathway. Adv Exp Med Biol2007; 597: 160–172.
47.
RemouchampsCBoutaffalaLGaneffCDejardinE. Biology and signal transduction pathways of the lymphotoxin-alphabeta/LTbetaR system. Cytokine Growth Factor Rev2011; 22: 301–310.
48.
AmerioPFrezzoliniAAbeniD, et al.Increased IL-18 in patients with systemic lupus erythematosus: Relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity, but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol2002; 20: 535–538.
49.
BijlMReefmanEHorstGLimburgPCKallenbergCG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: Correlates with decreased serum levels of complement. Ann Rheum Dis2006; 65: 57–63.
50.
LopezAFHercusTREkertP, et al.Molecular basis of cytokine receptor activation. IUBMB Life2010; 62: 509–518.
51.
AhsanAHanGPanJ, et al.Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Apoptosis2015; 20: 1563–1576.
52.
CheemaGSRoschkeVHilbertDMStohlW. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum2001; 44: 1313–1319.
53.
WalportMJ. Complement and systemic lupus erythematosus. Arthritis Res2002; 4: S279–293.
54.
PerrinLHLambertPHMiescherPA. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis. Clin Exp Immunol1974; 16: 575–581.
55.
LertnawapanRBianARhoYH, et al.Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus. Lupus2012; 21: 279–287.
56.
GuoGMengYTanW, et al.Induction of apoptosis coupled to endoplasmic reticulum stress through regulation of CHOP and JNK in bone marrow mesenchymal stem cells from patients with systemic lupus erythematosus. J Immunol Res2015; 2015: 183738–183738.
57.
ZhangZLiuPWangJ, et al.Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway. Med Oncol2015; 32: 149–149.
58.
ByrneJCNi GabhannJStaceyKB, et al.Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin. J Immunol2013; 190: 5207–5215.
59.
ButtonKSIoannidisJPMokryszC, et al.Power failure: Why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci2013; 14: 365–376.
CalvaniNRichardsHBTucciMPannaraleGSilvestrisF. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol2004; 138: 171–178.
62.
WongCKLiEKHoCYLamCWK. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology2000; 39: 1078–1081.
63.
ParkMCParkYBLeeSK. Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus. Clin Rheumatol2004; 23: 225–229.
64.
SaikiOSaekiYTanakaT, et al.Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration. Arthritis Rheum1987; 30: 1289–1292.
TakeuchiTNakagawaTMaedaY, et al.Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus. Autoimmunity2001; 34: 115–122.
67.
PickeringMCWalportMJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology2000; 39: 133–141.
68.
MandersonAPBottoMWalportMJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol2004; 22: 431–456.
69.
MarkiewskiMMLambrisJD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol2007; 171: 715–727.
70.
DinuARMerrillJTShenCAntonovIVMyonesBLLahitaRG. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus1998; 7: 355–360.
71.
HykaNDayerJMModouxC, et al.Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood2001; 97: 2381–2389.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
